TOLAZINE
Live / Applied — First extension granted (statement of use) (as of 22 Oct 2025)
What this means for you
Not registered yet, but its 31 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98930348
- Mark type
- Stylized text
- Filed
- 31 Dec 2024
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Harry B. Ray
Goods and services
- Class 005 — Pharmaceuticals: Veterinary pharmaceutical, namely, xylazine reversing agent and antagonist for use in horses
Owner
- Cronus Pharma LLC, East Brunswick, NJ, US
- Cronus Pharma LLC, East Brunswick, NJ, US
Prosecution history
- 22 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2025 — SOU EXTENSION 1 GRANTED
- 21 Oct 2025 — SOU EXTENSION 1 FILED
- 21 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jul 2025 — ASSIGNED TO EXAMINER
- 31 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 31 May 2025 — NOTICE OF REVIVAL - E-MAILED
- 31 May 2025 — PETITION TO REVIVE-GRANTED